140 related articles for article (PubMed ID: 35984673)
21. Pharmaceutical cocrystals: walking the talk.
Bolla G; Nangia A
Chem Commun (Camb); 2016 Jun; 52(54):8342-60. PubMed ID: 27278109
[TBL] [Abstract][Full Text] [Related]
22. Design of two series of 1:1 cocrystals involving 4-amino-5-chloro-2,6-dimethylpyrimidine and carboxylic acids.
Rajam A; Muthiah PT; Butcher RJ; Jasinski JP; Wikaira J
Acta Crystallogr C Struct Chem; 2018 Sep; 74(Pt 9):1007-1019. PubMed ID: 30191892
[TBL] [Abstract][Full Text] [Related]
23. Multicomponent solid forms of the uric acid reabsorption inhibitor lesinurad and cocrystal polymorphs with urea: DFT simulation and solubility study.
Palanisamy V; Sanphui P; Prakash M; Chernyshev V
Acta Crystallogr C Struct Chem; 2019 Aug; 75(Pt 8):1102-1117. PubMed ID: 31380793
[TBL] [Abstract][Full Text] [Related]
24. New multi-component solid forms of anti-cancer drug Erlotinib: role of auxiliary interactions in determining a preferred conformation.
Sanphui P; Rajput L; Gopi SP; Desiraju GR
Acta Crystallogr B Struct Sci Cryst Eng Mater; 2016 Jun; 72(Pt 3):291-300. PubMed ID: 27240760
[TBL] [Abstract][Full Text] [Related]
25. Pharmaceutical cocrystals and poorly soluble drugs.
Thakuria R; Delori A; Jones W; Lipert MP; Roy L; Rodríguez-Hornedo N
Int J Pharm; 2013 Aug; 453(1):101-25. PubMed ID: 23207015
[TBL] [Abstract][Full Text] [Related]
26. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
[TBL] [Abstract][Full Text] [Related]
27. Investigation of supramolecular synthons and structural characterisation of aminopyridine-carboxylic acid derivatives.
Hemamalini M; Loh WS; Quah CK; Fun HK
Chem Cent J; 2014; 8():31. PubMed ID: 24887234
[TBL] [Abstract][Full Text] [Related]
28. Pharmaceutical cocrystals: along the path to improved medicines.
Duggirala NK; Perry ML; Almarsson Ö; Zaworotko MJ
Chem Commun (Camb); 2016 Jan; 52(4):640-55. PubMed ID: 26565650
[TBL] [Abstract][Full Text] [Related]
29. Implication of Coformer Structural Diversity on Cocrystallization Outcomes of Telmisartan with Improved Biopharmaceutical Performance.
Haneef J; Arora P; Chadha R
AAPS PharmSciTech; 2019 Dec; 21(1):10. PubMed ID: 31802267
[TBL] [Abstract][Full Text] [Related]
30. Cocrystals of diacerein: Towards the development of improved biopharmaceutical parameters.
Tomar S; Chakraborti S; Jindal A; Grewal MK; Chadha R
Int J Pharm; 2020 Jan; 574():118942. PubMed ID: 31830577
[TBL] [Abstract][Full Text] [Related]
31. Engineering a Remedy to Modulate and Optimize Biopharmaceutical Properties of Rebamipide by Synthesizing New Cocrystal: In Silico and Experimental Studies.
Jindal A; Singh R; Tomar S; Dureja J; Karan M; Chadha R
Pharm Res; 2021 Dec; 38(12):2129-2145. PubMed ID: 34904202
[TBL] [Abstract][Full Text] [Related]
32. Quaternary cocrystals: combinatorial synthetic strategies based on long-range synthon Aufbau modules (LSAM).
Dubey R; Mir NA; Desiraju GR
IUCrJ; 2016 Mar; 3(Pt 2):102-7. PubMed ID: 27006773
[TBL] [Abstract][Full Text] [Related]
33. Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization.
Nijhawan M; Santhosh A; Babu PR; Subrahmanyam CV
Drug Dev Ind Pharm; 2014 Sep; 40(9):1163-72. PubMed ID: 23829186
[TBL] [Abstract][Full Text] [Related]
34. Cocrystallization: Cutting Edge Tool for Physicochemical Modulation of Active Pharmaceutical Ingredients.
Kumari N; Ghosh A
Curr Pharm Des; 2020; 26(38):4858-4882. PubMed ID: 32691702
[TBL] [Abstract][Full Text] [Related]
35. Bioavailability of indomethacin-saccharin cocrystals.
Jung MS; Kim JS; Kim MS; Alhalaweh A; Cho W; Hwang SJ; Velaga SP
J Pharm Pharmacol; 2010 Nov; 62(11):1560-8. PubMed ID: 21039541
[TBL] [Abstract][Full Text] [Related]
36. Supramolecular architectures in two 1:1 cocrystals of 5-fluorouracil with 5-bromothiophene-2-carboxylic acid and thiophene-2-carboxylic acid.
Mohana M; Thomas Muthiah P; McMillen CD
Acta Crystallogr C Struct Chem; 2017 Jun; 73(Pt 6):481-485. PubMed ID: 28579571
[TBL] [Abstract][Full Text] [Related]
37. Structural variety of heterosynthons in linezolid cocrystals with modified thermal properties.
Khalaji M; Wróblewska A; Wielgus E; Bujacz GD; Dudek MK; Potrzebowski MJ
Acta Crystallogr B Struct Sci Cryst Eng Mater; 2020 Oct; 76(Pt 5):892-912. PubMed ID: 33017322
[TBL] [Abstract][Full Text] [Related]
38. Cocrystal and its Application in the Field of Active Pharmaceutical Ingredients and Food Ingredients.
Wang N; Xie C; Lu H; Guo N; Lou Y; Su W; Hao H
Curr Pharm Des; 2018; 24(21):2339-2348. PubMed ID: 29788878
[TBL] [Abstract][Full Text] [Related]
39. Synthon preference in a hydrated β-resorcylic acid structure and its cocrystal with thymine.
Sridhar B
Acta Crystallogr C Struct Chem; 2015 Dec; 71(Pt 12):1042-7. PubMed ID: 26632828
[TBL] [Abstract][Full Text] [Related]
40. Artemisinin Cocrystals for Bioavailability Enhancement. Part 1: Formulation Design and Role of the Polymeric Excipient.
Kaur M; Yardley V; Wang K; Masania J; Botana A; Arroo RRJ; Li M
Mol Pharm; 2021 Dec; 18(12):4256-4271. PubMed ID: 34723557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
